Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Neurol ; 24(11): 1375-1383, 2017 11.
Article in English | MEDLINE | ID: mdl-28891262

ABSTRACT

BACKGROUND AND PURPOSE: The majority of Parkinson's disease (PD) patients suffer from gastrointestinal symptoms of which constipation is considered the most prominent. Recently, in addition to constipation, a diagnosis of irritable bowel syndrome (IBS) was also found to be associated with increased PD risk. Gut microbiota alterations have been reported in IBS and recently also in PD. IBS-like bowel symptoms in PD and their possible connection to other non-motor symptoms and faecal microbiota were assessed. METHODS: This case-control study compared 74 PD patients with 75 controls without any signs of parkinsonism or potential premotor symptoms. IBS-like symptoms were assessed using the Rome III questionnaire. The non-motor symptoms were assessed using the Non-Motor Symptoms Questionnaire and Non-Motor Symptom Scale. Faecal microbiota were assessed by pyrosequencing of the V1-V3 regions of the bacterial 16S ribosomal RNA gene. RESULTS: Symptoms that were IBS-like were significantly more prevalent in PD patients than in controls (24.3% vs. 5.3%; P = 0.001). Criteria for functional constipation were met by 12.2% of PD patients and 6.7% of controls (P = 0.072). PD patients with IBS-like symptoms had more non-motor symptoms and a lower faecal abundance of Prevotella bacteria than those without IBS-like symptoms. CONCLUSION: Our results indicate that PD patients may suffer from colonic dysfunction beyond pure constipation. Therefore, a more comprehensive assessment of bowel symptoms could provide valuable information. The lower abundance of Prevotella bacteria in PD patients with IBS-like symptoms suggests that the microbiota-gut-brain axis may be implicated in the gastrointestinal dysfunction of PD patients.


Subject(s)
Constipation/complications , Feces/microbiology , Gastrointestinal Microbiome , Irritable Bowel Syndrome/complications , Parkinson Disease/complications , Aged , Case-Control Studies , Constipation/microbiology , Constipation/physiopathology , Female , Humans , Irritable Bowel Syndrome/microbiology , Irritable Bowel Syndrome/physiopathology , Male , Middle Aged , Parkinson Disease/microbiology , Parkinson Disease/physiopathology , Surveys and Questionnaires
2.
Acta Neurol Scand ; 126(4): e17-9, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22299654

ABSTRACT

BACKGROUND: Patients with posterior ischemic stroke were usually excluded from thrombolytic treatment in clinical trials and clinical practice, and little is known about effectiveness of thrombolysis treatment in such patients who may end up with severe disability. AIMS OF THE STUDY: We aimed to describe the outcome of acute ischemic stroke patients presenting with isolated homonymous hemianopia and treated with intravenous thrombolysis. METHODS: A case report of three patients presenting with homonymous hemianopia owing to posterior circulation stroke treated with intravenous thrombolysis at the Helsinki University Central Hospital. Main outcome measures were modified Rankin Scale and neuropsychological examination at 3 months after thrombolysis. We further evaluated Goldmann visual field examination at 6 months. RESULTS: No acute findings appeared on admission non-contrast head-computed tomography scan. All patients had a perfusion deficit on admission-computed tomography perfusion imaging. All patients scored 0 on 3-month modified Rankin Scale, and their neuropsychological evaluation was normal. Goldmann examination revealed no visual field deficit in both female patients, and a modest visual field defect was detected in the male patient. CONCLUSIONS: Our experience encourages application of intravenous thrombolytic treatment (especially when supported with multimodality neuroimaging) in patients with homonymous hemianopia, for which rehabilitation options are limited.


Subject(s)
Fibrinolytic Agents/administration & dosage , Hemianopsia/drug therapy , Hemianopsia/etiology , Stroke/complications , Stroke/drug therapy , Administration, Intravenous , Adult , Aged , Brain Infarction/etiology , Brain Infarction/pathology , Cerebral Angiography , Female , Hemianopsia/diagnostic imaging , Humans , Male , Middle Aged , Stroke/diagnostic imaging , Tomography, X-Ray Computed , Visual Fields/drug effects
3.
Eur Neuropsychopharmacol ; 12(6): 587-99, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12468022

ABSTRACT

The density of transmitter receptors varies between different locations in the human cerebral cortex. We hypothesized that this variation may reflect the cyto- and myeloarchitectonical as well as the functional organisation of the cortex. We compared data from different imaging modalities (postmortem studies: cyto- and myeloarchitecture, quantitative in vitro receptor autoradiography; in vivo studies: PET receptor neuroimaging) in order to test our hypothesis. The regional and laminar distribution of the densities of numerous receptor types representing all classical transmitter systems as well as the adenosine system are visualized and measured in different cortical areas. The receptor distribution patterns segregate motor, primary sensory, unimodal sensory, multimodal association and other functionally identified cortical areas from each other. Areas of similar function show similar receptor fingerprints and differ from those with other properties. Thus, receptor distribution patterns reflect an organisational structure strictly correlated with the architectonics and functions of the human cerebral cortex.


Subject(s)
Cerebral Cortex/metabolism , Receptors, Neurotransmitter/metabolism , Aged , Autoradiography , Cerebral Cortex/anatomy & histology , Cerebral Cortex/diagnostic imaging , Female , Humans , In Vitro Techniques , Male , Middle Aged , Radioligand Assay , Receptors, Adrenergic/metabolism , Receptors, Cholinergic/metabolism , Receptors, Dopamine/metabolism , Receptors, GABA/metabolism , Receptors, Glutamate/metabolism , Receptors, Purinergic P1/metabolism , Receptors, Serotonin/metabolism , Tomography, Emission-Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...